Silence Therapeutics Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Silence Therapeutics stock has a consensus rating of "Buy" and an average price target of $31.2. The average 1-year stock price forecast is 440.73% higher than the current stock price, while the lowest is $4.00 (-30.68%) and the highest is $75 (+1,199.83%).

Price Target: $31.2 (+440.73%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.00	$31.2	$25	$75
Change	-30.68%	+440.73%	+333.28%	+1199.8%

* Price targets were last updated on Mar 13, 2026.

Analyst Ratings

The average analyst rating for Silence Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	3	3	3
Buy	2	2	2	1	1	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	0
Total	6	6	6	5	5	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick R. Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $75	Strong Buy	Reiterates	$75	+1,199.83%	Mar 13, 2026
Patrick R. Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $75	Strong Buy	Reiterates	$75	+1,199.83%	Sep 16, 2025
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $35	Strong Buy	Maintains	$35	+506.59%	Aug 8, 2025
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $75	Strong Buy	Reiterates	$75	+1,199.83%	Jun 13, 2025
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Maintains $35	Strong Buy	Maintains	$35	+506.59%	Jun 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 559.00K

Revenue Next Year

n/a

EPS This Year

n/a

from -1.88

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	16.81M	21.66M	31.64M	43.26M	559.00K
Revenue Growth	124.73%	28.82%	46.12%	36.71%	-98.71%
EPS	-1.80	-1.56	-1.46	-0.98	-1.88
EPS Growth	-	-	-	-	-
Forward PE	-	-	-	-	-
No. Analysts	-	-	-	-	-

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue
High
Avg
Low

Revenue Growth

Revenue Growth
High
Avg
Low

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.